Comparison of Tenofovir, Zidovudine, or Stavudine as Part of First-Line Antiretroviral Therapy in a Resource-Limited-Setting: A Cohort Study

Open Access

Peer-reviewed

Research Article

Kavindhran Velen,

Affiliation The Aurum Institute, Johannesburg, South Africa
⨯
James J. Lewis,

Affiliations The Aurum Institute, Johannesburg, South Africa, London School of Hygiene and Tropical Medicine, London, United Kingdom
⨯
Salome Charalambous,

Affiliation The Aurum Institute, Johannesburg, South Africa
⨯
Alison D. Grant,

Affiliation London School of Hygiene and Tropical Medicine, London, United Kingdom
⨯
Gavin J. Churchyard,

Affiliations The Aurum Institute, Johannesburg, South Africa, London School of Hygiene and Tropical Medicine, London, United Kingdom
⨯
Christopher J. Hoffmann

* E-mail: choffmann@auruminstitute.org

Affiliations The Aurum Institute, Johannesburg, South Africa, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
⨯

Reader Comments (0)

HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
RNA analysis
Is the Subject Area "RNA analysis" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Reverse transcriptase inhibitors
Is the Subject Area "Reverse transcriptase inhibitors" applicable to this article?

Thanks for your feedback.
Death rates
Is the Subject Area "Death rates" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.